D
evelopment of the T cell begins with colonization of the thymic rudiment by bone marrow-derived hematopoietic precursors lacking membrane expression of the coreceptor molecules CD4 and CD8 (consequently known as double-negatives (DN) 4 ) (1, 2). DN thymocytes, while being the least numerous among the thymocyte subsets, are also developmentally the most dynamic (3) (4) (5) . Those DN cells that commit to the T cell lineage will undergo numerous gene rearrangement and fate-determining events, including ␣␤ or ␥␦ lineage commitment and, if the ␣␤TCR lineage is chosen, extensive proliferation and subsequent expression of CD4 and CD8.
To facilitate studies of early T cell development, DN thymocytes were further subdivided based on the cell surface expression of the Pgp-1 glycoprotein (CD44) and IL-2R␣ chain (CD25) into four sequential stages of development: CD44
Ϫ/low CD25 Ϫ (DN4) (reviewed in Refs. 3, 4, and 6). The major changes associated with TCR gene rearrangement and cellular expansion occur at the transition from DN3 to DN4 cells. Some or all of these changes are mediated by the pre-TCR, formed by association of the TCR␤ chain with the surrogate TCR␣ (pre-TCR␣ chain (pT␣)) at the DN3 stage (7, 8) . As a consequence, DN4 cells progress to the DP stage, where pT␣ expression is down-regulated as the TCR␣ chain becomes available to pair with TCR␤ (9, 10) . Subsequent expression of the ␣␤TCR complex thus enables appropriate selection of thymocytes depending on their TCR specificity and its proper interaction with self-MHC molecules (11) .
The importance of the pre-TCR was highlighted by experiments with knockout mice where the deletion of either of the pre-TCR components resulted in a severe decrease of thymic cellularity, apparently caused by an inefficient transition from DN3 to DN4 stages and/or inefficient thymocyte expansion (12, 13) . Despite these clear-cut experiments, the exact mechanistic role of the pre-TCR is rather obscure. Numerous functions have been attributed to the pre-TCR, including rescue from programmed cell death, proliferation, induction of CD4 and CD8 expression, induction of TCR␣ locus rearrangement, and induction of TCR␣␤ lineage commitment (reviewed in Refs. 8 and 14) . However, while the pre-TCR could directly mediate all of the above functions, it is equally plausible that it may directly induce one (albeit critical) outcome, such as rescue from apoptosis, that enables other events to occur in a pre-TCR-independent manner. In fact, evidence exists to support this view (15) (16) (17) .
To revisit this puzzle, we evaluated T cell development in a model where the limiting pre-TCR complex component, pT␣, was constitutively overexpressed. We generated transgenic mouse lines that expressed different levels of the pT␣ transgene under the transcriptional control of the p56 lck proximal promoter. Results of the characterization of these mice, presented below, highlight the importance of correct developmental regulation of TCR and pre-TCR component expression and stoichiometry for optimal T cell differentiation.
Materials and Methods

Mice
Mice were bred and maintained under specific pathogen-free conditions in the Memorial Sloan-Kettering Cancer Center Research Animal Resource Center (New York, NY). Full-length pT␣ cDNA was inserted into the BamHI site of the expression cassette p1017 (18) . The transgene was released from the vector by NotI digestion, purified, and injected into (C57BL/6J ϫ CBA/CaJ) F 2 fertilized eggs. Transgenic founders were identified by Southern blot analysis of BamHI-digested genomic tail DNA using the pre-T␣ cDNA as a probe. Relative copy number was determined by comparison with the construct loaded at a known copy number. The transgenic lines were backcrossed to C57BL/6J background for more than nine generations at the time of analysis, which was conducted on separate mice between 8 and 13 wk of age.
RT-PCR
Total RNA was isolated from mouse thymocytes using TRIzol reagent (Life Technologies, Rockville, MD). RNA was reverse transcribed using random primers following the instructions of the manufacturer (Stratagene, La Jolla, CA). PCR was performed using primers complementary to sequences in the 5Ј and 3Ј ends of pT␣ (5Ј-CTGCAACTGGGTCATG CTTC-3Ј and 5Ј-TCAGACGGGTGGGTAAGATC-3Ј) and ␤-actin (Stratagene) as a housekeeping gene. Amplification was performed for indicated cycles at an annealing temperature of 55°C using a thermal cycling machine (PerkinElmer/Cetus, Norwalk, CT). After amplification, 10 l of the reaction mixture was resolved on a 1.3% agarose gel, blotted to a nylon membrane, and hybridized with a purified fragment specific for each cDNA.
Flow cytometric analysis
Single cell suspensions were obtained from thymi, stained with the indicated Abs, and analyzed using a FACScan instrument and CellQuest 3.1 software (BD Biosciences, Mountain View, CA). DN cells were prepared from total thymocytes by two cycles of anti-CD4 and anti-CD8 mAb plus complement-mediated depletion as previously described (19) . Cell surface expression of CD markers was determined using anti-CD4-tricolor, anti-CD8 FITC, anti-CD8 PE, anti-CD25 PE, anti-CD25 biotin, anti-CD44 PE (Caltag Laboratories, San Francisco, CA), and anti-CD44 CyChrome (BD PharMingen, San Diego, CA) mAbs. T3.70 (H-Y-specific TCR␣ chain) was purified from ascites and conjugated to biotin in our laboratory. PElabeled streptavidin was purchased from Caltag Laboratories. Hybridoma (2F5) producing mAb specific for the extracellular domain of pT␣ was kindly provided by Dr. H. von Boehmer (Dana-Farber Cancer Institute, Boston, MA). The 2F5 mAb was purified and conjugated to biotin in our laboratory. Signal observed with this Ab was amplified using the secondary reagent streptavidin-PBXL3 (Martek Biosciences, Columbia, MD).
Apoptosis assay
Thymocytes were suspended in ice-cold PBS containing 10% FCS. Where required, DN cells were prepared as above. Cells were cultured in 10% FCS-RPMI 1640 at a concentration of 1 ϫ 10 6 cells/ml (37°C) and aliquots were removed at 0, 12, 18, or 24 h to assess apoptosis. Surface staining was conducted with anti-CD4 tri-color (TC) plus anti-CD8 PE for total thymocytes, or with anti-CD25 PE plus anti-CD44 CyChrome for DN thymocytes. Cells were washed twice with PBS then incubated in 250 l of binding buffer (10 mM HEPES/NaOH (pH 7.4), 140 mM NaCl, and 2.5 mM CaCl 2 ) containing 2.5 l annexin V-FITC (BD PharMingen) for 15 min in the dark. Samples were analyzed by flow cytofluorometry (FCM) within 1 h. Annexin ϩ cells were scored as dead (apoptotic and necrotic) in some assays where the propidium iodide (PI) cytofluorometer channel was required to detect other fluorophores used to gate on a selective population of cells. In other assays, cells were purified and annexin staining was used in conjunction with PI to discriminate between the early apoptotic and late apoptotic/necrotic cells. Results of both types of assays were concordant, revealing a significant early apoptotic component in each case. 
BrdU incorporation
Procedure used was modified from Refs. 20 -22. Briefly, one milligram of 5-bromo-2Ј-deoxyuridine (BrdU) was injected i.p. three times at 4-h intervals. The thymus was taken 12 h after the third injection. Thymocytes were immediately suspended in ice-cold PBS containing 10% FCS. Total thymocytes were distributed in Eppendorf tubes (5 ϫ 10 6 cells/tube) and incubated with 50 l of a mixture of anti-CD4 TC and anti-CD8 PE (both from Caltag Laboratories) at optimal dilutions for 20 min at 4°C. DN thymocytes were prepared as above and distributed in Eppendorf tubes (5 ϫ 10 6 cells/tube) and incubated with 50 l of a mixture containing anti-CD4 allophycocyanin, anti-CD8 allophycocyanin, anti-CD44 PE, and anti-CD25 biotin (all from Caltag Laboratories) at optimal dilutions for 20 min at 4°C. The cells were then washed and biotinylated Ab was revealed with streptavidin-CyChrome (BD PharMingen). After surface staining, cells were fixed in 200 l of 1% paraformaldehyde containing 0.01% Tween 20 for 48 h at 4°C in the dark. Cells were washed in PBS and then in 40 mM Tris-HCl, pH 8.0, containing 10 mM NaCl and 6 mM MgCl 2 , and thereafter incubated for 30 min at 37°C in the same buffer containing 50 U/ml dRNase I (Amersham Pharmacia Biotech, Piscataway, NJ). After washing in PBS containing 0.5% Tween 20, thymocytes were incubated with 5 l of anti-BrdU FITC (BD Biosciences) for 30 min at room temperature in the dark.
Metabolic labeling and immunoprecipitation
Thymocytes (30 ϫ 10 6 ) were labeled with 2 mCi 35 S-methionine (Amersham Pharmacia Biotech) for 1 h at 37°C. Cells were washed with ice-cold PBS and the pellet was lysed with 1% Triton X-100, 1% BSA, 0.5 mM PMSF, 0.1 mM N-␣-tosyl-L-lysine-chloromethyl-ketone and 5 mM iodoacetamide in TBS (10 mM Tris (pH 7.4) and 150 mM NaCl) for 30 min on ice. Lysates were centrifuged (2000 rpm for 5 min) and precleared overnight with 2 l of normal rabbit serum, 75 l of Zysorbin (Zymed Laboratories, San Francisco, CA) and 25 l of a 50% slurry of protein ASepharose (Sigma-Aldrich, St. Louis, MO). After centrifugation, precleared lysates were incubated with 10 g of Ab against the C-terminal (kindly provided by Dr. D. Wiest, Fox Chase Cancer Center, Philadelphia, PA) for 2 h and then protein A-Sepharose was added to bring down the immunocomplexes. Samples were resolved by SDS-PAGE and the polyacrylamide gel was fixed, soaked in the fluorographic reagent Amplify (Amersham Pharmacia Biotech) for 15 min, dried, and finally exposed to Kodak (Kodak, Rochester, NY) film at Ϫ80°C.
Results
Generation of pT␣-transgenic mice
To generate mice with constitutive expression of pre-TCR, we inserted murine pT␣ cDNA (kindly provided by Dr. H.-J. Fehling, University of Basel, Basel, Switzerland) into the p1017 cassette (obtained from Dr. R. Perlmutter, Amgen, Thousand Oaks, CA) under the transcriptional control of the p56 lck proximal promoter (Fig. 1A) . A NotI fragment of this construct (Fig. 1A ) was microinjected into fertilized oocytes of (C57BL/6 ϫ CBA) F 2 mice according to standard procedures, and four transgene (Tg) ϩ founders (F11, F23, F29, and F32) were obtained. Founders pT␣ Tg 11 and 32 expressed low Tg copy number (between two and four copies per genome), with F11 expressing less than F32 (data not shown). F11 mice are therefore referred to as pT␣ Tg low . Founders 23 and 29 exhibited much higher Tg copy numbers (Ͼ20 copies per genome) and are together referred to as pT␣ Tg high . All the transgenic lines were backcrossed to C57BL/6 mice for over nine generations at the time of the analysis, giving rise to mouse lines 11, 23, 29, and 32. The expression of pT␣ mRNA was detected by RT-PCR and of the cell surface or cytosolic protein using a mAb specific for surface pT␣ (kindly provided by Dr. H. von Boehmer, Dana-Farber Cancer Institute), or a mAb against the C-terminal pT␣ peptide (generously supplied by Dr. D. Wiest, Fox Chase Cancer Center), as shown in Fig. 1 , C and D. Semiquantitative RT-PCR analysis indicated that the pT␣ message was present at a higher level in pT␣-Tg thymocytes compared with the wild type (wt); moreover, the level of mRNA expression appeared to be Tg copy dependent (Fig. 1B) . As previously reported, the low cell surface expression of pT␣ makes its detection by flow cytometry extremely difficult. Aifantis et al. (23) have shown that a combination of biotinylated mAb 2F5 and the enhancing fluorochrome reagent streptavidin-PBXL3 allows pT␣ detection in SCB29 cells. Using the same approach, we could detect a discrete but reproducible increase of pT␣ surface expression on pT␣-Tg DN cells (Fig. 1C) . This was independently corroborated by immunoprecipitation of metabolically labeled protein lysates using a mAb directed to the pT␣ C terminus. As shown in Fig. 1D , pT␣-Tg mice express higher levels of pT␣ protein compared with the wild type. Moreover, high copy number cell lines expressed more protein than the low copy number lines. We could not detect pT␣ expression by either method on single-positive (SP) thymocytes, nor on any of the peripheral T cell subsets (data not shown).
Thymic cellularity is reduced in mice overexpressing pT␣
Tg lines 23 and 29 (pT␣ Tg high ) exhibited a severe decrease in thymic cellularity. Of the two low copy number cell lines, line 32 had a moderate cellularity reduction, whereas line 11 had no reduction at all ( Fig. 2A) . This result suggests that constitutively overexpressed pT␣ unexpectedly perturbs normal T cell development in a copy number-dependent manner. Reduced thymocyte numbers could be due to reduced production or to increased elimination. The CD4/CD8 profiles in pT␣-Tg mice were not grossly affected, although an increase in the percentages of DN cells compared with littermate controls could be observed (Fig. 2D ). More importantly, in lines 23, 29, and 32, the absolute number of pT␣-Tg DN cells was not appreciably different in comparison with wild-type mice (Fig. 2B ), but the absolute number of DP cells was reduced (Fig. 2C) , indicating that thymic hypocellularity in these mice occurs due to a disturbance at the DP level.
pT␣-Tg overexpression potentiates DN3 to DN4 transition and thymocyte proliferation
The pre-TCR complex is first expressed and is believed to exert its function in a subset of DN3 cells (8, 24) . We therefore investigated in wild-type and Tg mice the biology of the DN3/4 transition, focusing on the Tg lines exhibiting low (line 11) or high Tg copy number (lines 23 and 29, which were phenotypically indistinguishable from one another). We found that the DN3/4 transition was potentiated in pT␣-Tg mice compared with corresponding littermate controls (Fig. 2D, bottom, and E and F) . The pT␣ transgene caused a copy number-dependent shift in DN4/DN3 ratios from 0.6 Ϯ 0.4 in wild-type animals to 3.0 Ϯ 0.8 in Tg low or Tg high lines (Fig. 2, D and F, and data not shown) .
To determine the cause of these changes in population dynamics, we assessed the proliferative potential and susceptibility to apoptosis of pT␣-Tg early thymocytes. This was particularly pertinent in light of certain models of pre-TCR function, which postulate that rescue from apoptosis alone (15, 16) or rescue from apoptosis and induction of proliferation (8, 24) are induced by this receptor. Mice were injected with BrdU i.p., and the percentage of incorporation of this nucleotide analog into newly synthesized DNA in each thymocyte subset was revealed by FCM (Fig. 3) . The pT␣-Tg thymocytes exhibited a transgene copy number-dependent increase in BrdU incorporation among DN, DP, and SP thymocytes, as compared with non-Tg counterparts (Fig. 3A) . Not surprisingly, the increase in proliferation was more evident in the DN and CD8 SP subsets, which in wild-type mice are known to be mitotically the most active (3).
Among the DN thymocyte subsets in normal mice, DN4 cells contain the bulk of proliferating cells, with DN3 cells being much less active (3, 25) , so that only a fraction of DN3 cells (10 -25%) are actively cycling. Consistent with these findings, we observed that 24.1 Ϯ 7.8% of DN3 and 64.8 Ϯ 6.3% of DN4 thymocytes labeled with BrdU in wild-type mice. By contrast, pT␣ overexpression induced a significant ( p Յ 0.09) increase in BrdU incorporation in DN3 cells and a somewhat decreased proliferation of DN4 cells (Fig. 3B) . This decrease was significant only in pT␣ Tg high DN4 cells. These data show that overexpression of pT␣ pronounces proliferation of the DN3 cells. It remains to be seen whether those Tg DN3 cells that proliferate are enriched in cells successfully rearranging the TCR␤ locus.
The pT␣ transgene induces increased survival of DN4 yet apoptosis of DP cells DP cells of pT␣-Tg high mice exhibit a marked reduction in cell numbers, decisively contributing to the overall reduction of thymic cellularity. In normal thymopoiesis, the expression of pT␣ is highest at DN3 and DN4 stages and is subsequently down-regulated to allow a proper interaction of successfully rearranged TCR␣ chains with TCR␤ in DP cells. In the transgenic system using the p56 lck proximal promoter, pT␣ expression is artificially sustained throughout intrathymic development (18) . We therefore considered the possibility that this constitutive expression may interfere with DP survival and final maturation. Indeed, freshly isolated thymocytes from pT␣-Tg high mice, where the hypoplasia of the thymus is more evident, exhibited a 3-to 4-fold higher proportion of apoptotic cells compared with the wild type ( Fig. 4A and results not shown). Moreover, when Tg and non-Tg thymocytes were cultured overnight in single cell suspension culture without additional stimulation, both low and high copy number DP cells showed an increase in annexin V ϩ cells (Fig. 4B) , indicating that these thymocytes exhibit a tendency to spontaneously die by a mechanism most likely triggered before disruption of the tissue for cell isolation. Again, the effect was copy number-dependent as Tg high DP thymocytes exhibited higher levels of annexin V ϩ cells than Tg low cells. By contrast, the Tg protected the immediate precursors of DP cells, the DN4 thymocytes, from apoptosis in a copy number-dependent manner (Fig. 4C ). This effect was not seen in DN1, DN2, DN3, or SP thymocytes (data not shown). We conclude that the effect of pT␣ overexpression is stage-specific, involving increased The proto-oncogene product Bcl-2 and tumor suppressor p53 exert their effects at sequential developmental points, so that apoptosis of DN3/4 cells at the pre-TCR checkpoint is controlled in a p53-dependent, Bcl-2-independent manner (26), while apoptosis of DP cells due to the lack of positive intrathymic selection proceeds largely independent of p53 but can be blocked by overexpression of Bcl-2 (27) . To prove that DP cells in pT␣-Tg mice are dying at an increased rate in vivo, we crossed them to mice overexpressing Bcl-2 (generously provided by Dr. H. Petrie, Memorial Sloan-Kettering Cancer Center, New York, NY). pT␣-Tg high /bcl-2 double-Tg mice showed full correction of thymic cellularity (Fig. 5A) , DP cell numbers (Fig. 5B) , and thymic volume (data not shown) to the levels observed in wild-type mice (data not shown) or mice singletransgenic for Bcl-2 (Fig. 5) . Surprisingly, in the case of pT␣-Tg low mice, where the apoptosis of DP cells is less pronounced due to lower Tg copy number, the presence of Bcl-2 resulted in larger thymic size and greater absolute numbers of DP cells (Fig. 5) . These results can be explained by the cooperative effects of increased proliferation of DN3 cells and reduced p53-mediated apoptosis caused by the pT␣ overexpression (Ref. 15 and this paper), and the apoptosis-blocking effects of Bcl-2 which neutralize the effects of the ectopic expression of pT␣ in DP cells. SP cells were produced at comparable levels in the mice from Fig. 5 process akin to negative selection. Alternatively, deregulated expression of pT␣ could interfere with TCR assembly and thus lead to less efficient positive selection. In that regard, previous results (26, 27) suggest that the bcl-2 transgene delays DP thymocyte death but does not interfere with negative selection.
Dysregulated pT␣ may interfere with ␣␤TCR formation and function
The enforced presence of overexpressed pT␣ in DP cells at the moment where the formation of the ␣␤TCR is indispensable for survival and further development is likely to affect TCR chain stoichiometry. This, in turn, has the potential to decrease the efficacy of ␣␤TCR formation and its interaction with the selecting self-MHC molecules. To test whether constitutive expression of pT␣ may be blocking the delivery of survival and/or selection signals, we crossed pT␣-Tg high mice with ␣␤TCR H-Y-Tg mice, where the TCR specificity and selection requirements are well established. Double-Tg female mice showed a 3-fold decrease in the proportion of CD8 SP cells (Fig. 6A) , with a reduction in the surface TCR-Tg ␣-chain (T3.70) levels within CD8 SP cells (mean fluorescence intensity for T3. 6 cells/ml) in 10% FCS-RPMI 1640 at 37°C and aliquots were removed at 0, 12, 18, or 24 h and stained with annexin V-FITC, plus anti-CD4 PE and anti-CD8 CyChrome (for DP gating (B)) or anti-CD3/CD4/CD8 allophycocyanin, anti-CD25 PE and anti-CD44 CyChrome (for DN subset gating (C)). PI staining could not be included in these experiments due to use of the required channel for detection of other fluorochromes. Results shown are the mean of three individual experiments (SD Ͻ 10%). overlapping SD; see Fig. 6B ), suggesting that breeding of a TCR-Tg onto pT␣ high background does not lead to further depletion of DP cells by negative selection. By contrast, absolute numbers of CD8 SP cells are higher in pT␣ high ϫ H-Y TCR-Tg double-Tg than in pT␣ high thymi but lower than in H-Y TCR-Tg mice (Fig. 6B) , suggesting that excess of TCR␣ helps positive selection in double-Tg mice. This finding indirectly favors the "interference with TCR assembly" alternative, a possibility also consistent with previous observations that premature ␣␤TCR expression competes with the pre-TCR in DN cells, leading to curtailed development toward DP cells (28, 29) . Both observations suggest that pre-TCR and TCR stoichiometry is crucial for proper developmental progression-first for the assembly of the pre-TCR in DN thymocytes (in the absence of ␣␤TCR) and then for the assembly of the ␣␤TCR (in the absence of pT␣-TCR␤).
Because the stoichiometry of TCR molecules apparently plays an important role in development, we evaluated whether supplying more functional TCR␤ chains to the pT␣ Tg may further enhance the transition regulated by the pre-TCR. The presence of a rearranged TCR␤ chain (V␤5 transgenic from the OT-1 TCR), together with pT␣ Tg high , did not result in appreciable correction of thymic cellularity (average cellularity of two mice in this experiment: wild type, 119 ϫ 10 6 ; pT␣ Tg, 57 ϫ 10 6 ; V␤5, 108 ϫ 10 6 ; V␤5/pT␣ double-Tg, 50 ϫ 10 6 cells), but rather in an even more efficient transition from the DN3 to DN4 stage, as judged by an overwhelming dominance of DN4 cells in the DN compartment (Fig. 7) . That provision of additional TCR␤ chains did not correct thymic cellularity is consistent with the conclusion that the primary defect in pT␣-Tg high DP thymocytes must be in competitive disruption of ␣␤TCR formation by the transgene. Based upon these findings, we conclude that the levels of pT␣, rather than of the TCR␤ chain, are limiting for the DN3 and DN4 transition in vivo. This notion is further supported by the more efficient DN3 to DN4 transition in pT␣-Tg high mice.
Discussion
Due to low expression levels and difficult detection, at present the mode of operation and the precise function of the pre-TCR are still incompletely understood. Most of our knowledge was shaped by findings obtained from genetically manipulated models that were used to investigate the consequences of pre-TCR expression and signaling and to address whether the pre-TCR recognizes an extracellular ligand. In one such study, a version of pT␣ lacking the cytosolic domain (tailless pT␣), controlled by the p56 lck promoter (30) , was shown to function nearly as efficiently as the whole molecule. Another group showed that the intracellular domain, devoid of most of the extracellular domain, also apparently functions comparably to the full molecule (31) . Although both groups studied heavily overexpressed molecules (possibly subject to caveats of spontaneous aggregation and signaling), their conclusions led to the hypothesis that recognition of an extracellular ligand may not be required for the pre-TCR function. Consistent with this hypothesis, it was found that pre-TCR localizes to the liposoluble membrane microdomains ("rafts") in the absence of signals from the thymic microenvironment (32) , and that ligation of the pre-TCRassociated CD3⑀ chain leads to calcium signaling (33) . These findings strongly suggest that either there is no extracellular ligand for pre-TCR or this ligand is provided in a cell-autonomous or homotypic fashion. An even more difficult question, not decisively answered so far, is which of the changes occurring in the aftermath of pre-TCR expression can be directly ascribed to the pre-TCR itself and which, if any, are produced by concurrent or immediately subsequent signaling via pre-TCR-independent pathways.
Experiments presented here provide a new angle to these issues owing to the presence of graded and different amounts of the transgene in different mouse lines. Our transgene was expressed under the control of the proximal lck promoter, known to be activated in early T cell development, between the DN2 and DN4 stages (18, 34) . Our results demonstrate that qualitatively and quantitatively constitutive expression of pT␣ potentiates many of the features of early T cell development at the DN/DP interface in a strictly developmentally regulated manner. We conclude that pT␣ must be the limiting chain of the pre-TCR complex, because providing an excess of this chain accelerated the DN3-to-DN4 transition. It is interesting that the effects of the transgene were strictly stage specific, with three thymocyte populations exhibiting three distinct effects. The effects of the Tg were first observed in DN3 thymocytes (in which the proximal lck promoter first becomes activated; Ref. 34) in the form of increased proliferation, the extent of which correlated with the transgene dosage. Perhaps somewhat surprisingly, Tg DN4 cells, known to undergo major expansion in normal mice, survived better, but actually proliferated slightly less, than non-Tg cells. Again, pT␣ Tg levels quantitatively correlated with increased survival and decreased proliferation. Finally, at the DP stage, the Tg caused increased apoptosis in a copy number-dependent fashion. Although this could be caused by Tg toxicity, we believe that this is not the case, because even the low (barely detectable; ϳ1-2 copies of Tg) levels of Tg caused increased DP apoptosis. Moreover, these same Tg doses did not cause apoptosis at the two preceding stages of development (DN3 and DN4), and it is difficult to envision why nonspecific toxicity would be selectively developmentally regulated. It is also possible that pT␣ provides a strong signal to DP cells that alone, or synergistically with TCR␣␤, causes their apoptosis or that increased apoptosis is due to pT␣ competition with TCR␣ for TCR␤, leading to decreased TCR␣␤ assembly and a consequent lack of efficient positive selection. This explanation was supported by suggestive, but not definitive, findings of reduced TCR␣ expression and inefficient positive selection in pT␣/H-Y TCR double-Tg mice.
Overall, the results presented in this study underline the importance of correct temporal regulation of pre-TCR. Moreover, our data also point to an important role of chain stoichiometry and TCR assembly. Thus, we previously showed (see Fig. 8 , middle) premature expression of TCR␣ (as is the case in TCR-Tg mice) takes away TCR␤ chains from the pre-TCR complex, curtailing expansion and imprinting the mature DN developmental fate upon many of the cells that express this complex (29) . By contrast, providing excess of pT␣ increases proliferation of DN3 cells and survival of DN4 cells, but the failure to extinguish this expression at the DP stage reduces formation of ␣␤TCR and increases DP cell apoptosis that can be blocked by Bcl-2 overexpression. It will be of interest to further dissect the developmental effects of overexpressed pT␣ upon the regulation of cell cycle in the course of the DN/DP transition.
